Benzodiazepines
Benzodiazepine overdose is common and typically only severe when complicated by:
- Co-ingestion of CNS depressant
- Pulmonary or cardiac disease
- Extremes of age
Epidemiology and Risk Factors
Pathophysiology
Aetiology
Clinical Manifestations
Typically:
- Drowsiness
- Dysarthria
- Ataxia
- Nystagmus
Occasionally:
- Paradoxical agitation
- Confusion
Diagnostic Approach and DDx
Investigations
Bedside:
Laboratory:
Imaging:
Other:
Management
Resuscitation:
Specific therapy:
- Pharmacological
- Flumazenil
- Not licensed for use in poisoning
- Risk of VT, status epilepticus, or benzodiazepine withdrawal
- Dosing:
- 0.1mg per 1mg of midazolam
- 0.2mg IV Q30s empirically
- Up to 3-5mg as an initial dose, with repeated doses up to 3mg/hr
- Flumazenil
- Procedural
- Physical
Supportive care:
Disposition:
Preventative:
Marginal and Ineffective Therapies
Anaesthetic Considerations
Complications
Prognosis
Key Studies
References
- Bersten, A. D., & Handy, J. M. (2018). Oh’s Intensive Care Manual. Elsevier Gezondheidszorg.